One Last SPAC to Close Out August and Bring the Month’s Deal Count to Seven.
To cap off a very busy August, Longevity Acquisition Corporation, filed their CERT today, indicating they will be pricing their IPO tonight for trading Wednesday (Nasdaq: LOACU).
Longevity, which will be focusing on companies in China, will be looking to raise $40 million at IPO. However, there is always the possibility of an upsize given how attractive the China-focused SPAC structures are to investors. Specifically, the terms provide 12 months to find an acquisition, but with three(3) 3-month extensions possible with an increase of $0.10 per share added to the trust for each extension.
The $40 million Longevity deal ends the SPAC-abundant summer on a high note. To give some perspective on just how busy it actually was, in the past three months alone, (June, July, and August), there will be 16 deals, including Longevity, raising total gross proceeds of $3.772 billion. Looking at January through May, which has two extra months, only $3.354 billion was raised over 15 deals.
We have four more months left in the year. Anybody want to start a pool on what we think final deal count and gross proceeds will be?
Cantor is sole bookrunning manager for Longevity Acquisition Corp.
Longevity Acquisition Corporation Summary of Terms:
- Focus: China
- Size: $40 million
- $10.00 unit comprised of one Ordinary Share + one Warrant (1/2 share) + one Right
- Each Right entitles the holder to receive one-tenth (1/10) of one Share
- Warrant call for redemption threshold: equals or exceeds $18.00 (cash or cashless exercise)
- 100% held in trust ($10.00 per share)
- Life: 12 months to complete an acquisition + three 3-month extensions ($0.10/share added to Trust for each extension)
- Limitation on Redemption Rights: 15%
- At-risk Capital: $2.7 million (270K private placement units, Cantor participating for 20K units)
- Underwriter fees: 3.0% + 2.5% deferred.
Cantor Fitzgerald is sole book-runner.
Ellenoff Grossman & Schole LLP and Loeb & Loeb LLP are Issuer’s Counsel and Underwriter’s Counsel, respectively.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...